Answers are grounded in this paper and cite their sources.
In recent years, it has been noted that the combination of radiation and immunotherapy is more benefitial than both modalities used separately. The interactions between immune checkpoint inhibitors and high-dose radiotherapy are curently an important topic of ongoing scientific trials. This review highlights some of the presented papers during the ESTRO 37 congress in 2018.
No takes yet. Share an insight, caveat, or question.
Adam Deja (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: